These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2872315)

  • 1. Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in-vitro.
    Trulson ME; Arasteh K
    J Pharm Pharmacol; 1986 May; 38(5):380-2. PubMed ID: 2872315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone decreases the activity of serotonin-containing neurons in the dorsal raphe in freely-moving cats.
    Trulson ME; Trulson TJ
    Neuropharmacology; 1986 Nov; 25(11):1263-6. PubMed ID: 2879255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.
    VanderMaelen CP; Matheson GK; Wilderman RC; Patterson LA
    Eur J Pharmacol; 1986 Sep; 129(1-2):123-30. PubMed ID: 2876903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of buspirone on single unit activity in locus coeruleus and dorsal raphe nucleus in behaving cats.
    Wilkinson LO; Abercrombie ED; Rasmussen K; Jacobs BL
    Eur J Pharmacol; 1987 Apr; 136(1):123-7. PubMed ID: 3595712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone increases locus coeruleus noradrenergic neuronal activity in vitro.
    Trulson ME; Henderson LJ
    Eur J Pharmacol; 1984 Oct; 106(1):195-7. PubMed ID: 6529967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone-induced changes in the serotonergic and non-serotonergic cells in the dorsal raphe nucleus of rats.
    Jahanshahi A; Lim LW; Steinbusch HW; Visser-Vandewalle V; Temel Y
    Neurosci Lett; 2010 Apr; 473(2):136-40. PubMed ID: 20178829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
    Matos FF; Korpinen C; Yocca FD
    Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The presynaptic metabolic modulation of the impulse-dependent release of 3H-serotonin from rat brain slices by ipsapirone (TVX Q 7821) and other serotonin agonists].
    Dolzhenko AT; Traber J; Glaser T; De Vry J
    Eksp Klin Farmakol; 1993; 56(4):9-12. PubMed ID: 8106062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
    Yocca FD
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurophysiological effects of buspirone and isapirone in the hippocampus: comparison with 5-hydroxytryptamine.
    Rowan MJ; Anwyl R
    Eur J Pharmacol; 1986 Dec; 132(1):93-6. PubMed ID: 2880731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone.
    Carli M; Prontera C; Samanin R
    Br J Pharmacol; 1989 Apr; 96(4):829-36. PubMed ID: 2568143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus.
    Andrade R; Nicoll RA
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):5-10. PubMed ID: 2888027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the electrophysiological and pharmacological properties of serotonin-containing neurons in the nucleus raphe dorsalis, raphe medianus and raphe pallidus recorded from mouse brain slices in vitro: role of autoreceptors.
    Trulson ME; Frederickson CJ
    Brain Res Bull; 1987 Feb; 18(2):179-90. PubMed ID: 2436725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone, a non-benzodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity.
    Sanghera MK; McMillen BA; German DC
    Eur J Pharmacol; 1982 Dec; 86(1):107-10. PubMed ID: 6130954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
    Ballarín M; Carceller A; Guitart X
    Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
    Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ
    Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.
    Blier P; de Montigny C
    Synapse; 1987; 1(5):470-80. PubMed ID: 2905533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways.
    Casanovas JM; Artigas F
    J Neurochem; 1996 Nov; 67(5):1945-52. PubMed ID: 8863499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of buspirone in a putative model of anxiety in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES
    J Pharm Pharmacol; 1988 Jul; 40(7):494-500. PubMed ID: 2904990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.